Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Resmed (RSMDF) Goodwill (2016 - 2025)

Historic Goodwill for Resmed (RSMDF) over the last 16 years, with Q4 2025 value amounting to $3.0 billion.

  • Resmed's Goodwill rose 852.0% to $3.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.0 billion, marking a year-over-year increase of 852.0%. This contributed to the annual value of $3.0 billion for FY2025, which is 719.99% up from last year.
  • Per Resmed's latest filing, its Goodwill stood at $3.0 billion for Q4 2025, which was up 852.0% from $3.0 billion recorded in Q3 2025.
  • In the past 5 years, Resmed's Goodwill registered a high of $3.0 billion during Q2 2025, and its lowest value of $1.9 billion during Q3 2021.
  • Moreover, its 5-year median value for Goodwill was $2.8 billion (2023), whereas its average is $2.5 billion.
  • In the last 5 years, Resmed's Goodwill soared by 4504.23% in 2023 and then plummeted by 197.43% in 2024.
  • Over the past 5 years, Resmed's Goodwill (Quarter) stood at $2.0 billion in 2021, then surged by 41.8% to $2.8 billion in 2022, then grew by 3.42% to $2.9 billion in 2023, then decreased by 1.97% to $2.8 billion in 2024, then rose by 8.52% to $3.0 billion in 2025.
  • Its Goodwill stands at $3.0 billion for Q4 2025, versus $3.0 billion for Q3 2025 and $3.0 billion for Q2 2025.